McKesson Corporation

MCK

US58155Q1031

Pharmaceuticals

Delayed Nyse Other stock markets 16:00:02 2026-02-13 EST			5-day change	1st Jan Change
934.75 ^USD	+2.05%		-1.47%	+13.95%

02-13	McKesson Insider Sold Shares Worth $282,817, According to a Recent SEC Filing	MT
02-10	JPMorgan Adjusts Price Target on McKesson to $1,107 From $983, Maintains Overweight Rating	MT

McKesson boosts 2026 profit forecast amid specialty drug growth

Published on 02/04/2026 at 05:42 pm EST

Reuters

Latest news about McKesson Corporation

02-13	McKesson Insider Sold Shares Worth $282,817, According to a Recent SEC Filing	MT
02-10	JPMorgan Adjusts Price Target on McKesson to $1,107 From $983, Maintains Overweight Rating	MT
02-09	Firebrick Pharma Limited Appoints Al Moghaddam as Non-Executive Director, Effective March 1, 2026	CI
02-05	US Equity Markets Fall on Weak Jobs Data, Tech Slump	MT
02-05	Sector Update: Health Care Stocks Softer Late Afternoon	MT
02-05	Sector Update: Health Care	MT
02-05	Top Midday Gainers	MT
02-05	Equities Fall Intraday as Markets Assess Earnings, Macro Data Ahead of Amazon Results	MT
02-05	Cardinal Health boosts annual profit forecast on surging demand for specialty drugs	RE
02-05	TD Cowen Adjusts McKesson PT to $1,012 From $1,000, Maintains Buy Rating	MT
02-05	Jefferies & Co Adjusts McKesson Price Target to $1,065 From $975, Maintains Buy Rating	MT
02-05	Leerink Partners Adjusts McKesson PT to $975 From $965, Maintains Outperform Rating	MT
02-05	Baird Adjusts McKesson Price Target to $974 From $968, Maintains Outperform Rating	MT
02-05	Wells Fargo Adjusts McKesson Price Target to $925 From $914, Maintains Equal Weight Rating	MT
02-05	Mizuho Securities Adjusts McKesson Price Target to $885 From $880, Maintains Neutral Rating	MT

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.

Employees

44,000

Sector

Pharmaceuticals

Calendar

03-01 -

More about the company